Higher serum level of CTRP15 in patients with coronary artery disease is associated with disease severity, body mass index and insulin resistance

Shokoohi Nahrkhalaji, Abolfazl and Ahmadi, Reza and Fadaei, Reza and Panahi, Ghodratollah and Razzaghi, Malihe and Fallah, Soudabeh (2020) Higher serum level of CTRP15 in patients with coronary artery disease is associated with disease severity, body mass index and insulin resistance. Archives of Physiology and Biochemistry. pp. 1-5. ISSN 1381-3455

Full text not available from this repository.
Official URL: https://www.scopus.com/record/display.uri?eid=2-s2...

Abstract

Background: CTRP15 is a prologue of adiponectin which has shown to have favourable effects on glucose and lipid metabolism. Studies have reported lower levels of CTRP15 in T2DM and metabolic syndrome; however, its circulating levels have not been evaluated in CAD patients. Methods: This case–control study was conducted on 190 angiographically confirmed coronary artery disease (CAD) patients and 70 controls. Serum levels of CTRP15, adiponectin, TNF-α, and IL-6 were measured using the ELISA technique. Results: CTRP15 was shown to occur in higher levels in CAD patients compared with controls. In CAD patients, CTRP15 showed a positive correlation with BMI, FBS, insulin, HOMA-IR, IL-6, and TNF-α and a negative correlation with HDL-C and adiponectin. Conclusion: Elevated levels of CTRP15 in CAD patients and the relation of CTRP15 with pathogenic conditions such as insulin resistance, inflammation, and decreased adiponectin and HDL-C suggest a possible compensatory response to these conditions in CAD patients

Item Type: Article
Subjects: WG Cardiovascular System
Divisions: Reserach Vice-Chancellar Department > Clinical Biochemistry Research Center
Depositing User: zeynab . bagheri
Date Deposited: 18 May 2020 05:47
Last Modified: 18 May 2020 05:47
URI: http://eprints.skums.ac.ir/id/eprint/8389

Actions (login required)

View Item View Item